Clinical Trial

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Study acronym: ECHOS
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this observational study is to evaluate the clinical outcomes of treatment with docetaxel, ARTA (alone or in combination) or with radiotherapy on the primary tumor for mCSPC, in an unselected population, in clinical practice
Trial Details
NCT Number NCT06473259
Lead Sponsor Santa Chiara Hospital
Conditions Prostate Cancer, Hormone Sensitive Prostate Cancer, Metastatic Tumor
Enrollment 3,000 participants
Start Date 2016-12-16
Primary Completion 2026-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-06-25